רבלימיד 15 מ"ג

Země: Izrael

Jazyk: hebrejština

Zdroj: Ministry of Health

Aktivní složka:

LENALIDOMIDE 15 MG

Dostupné s:

NEOPHARM SCIENTIFIC LTD

ATC kód:

L04AX04

Léková forma:

CAPSULES

Podání:

PER OS

Výrobce:

CELGENE EUROPE LTD, UK

Terapeutické skupiny:

LENALIDOMIDE

Terapeutické indikace:

1. Treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. In combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

Datum autorizace:

2009-04-01